<mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd"><id>2960810</id><setSpec>journal_article</setSpec><setSpec>doc-type:article</setSpec><setSpec>ddc:590</setSpec><setSpec>journal_articleFtxt</setSpec><setSpec>open_access</setSpec>

<genre>article</genre>

<titleInfo><title>Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review</title></titleInfo>


<note type="publicationStatus">published</note>


<note type="qualityControlled">yes</note>

<name type="personal">
  <namePart type="given">Barbara</namePart>
  <namePart type="family">Kaltschmidt</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">7702352</identifier></name>
<name type="personal">
  <namePart type="given">Kaya</namePart>
  <namePart type="family">Witte</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">285414110</identifier></name>
<name type="personal">
  <namePart type="given">Johannes</namePart>
  <namePart type="family">Greiner</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">22435190</identifier><description xsi:type="identifierDefinition" type="orcid">0000-0002-0524-662X</description></name>
<name type="personal">
  <namePart type="given">Florian</namePart>
  <namePart type="family">Weissinger</namePart>
  <role><roleTerm type="text">author</roleTerm> </role></name>
<name type="personal">
  <namePart type="given">Christian</namePart>
  <namePart type="family">Kaltschmidt</namePart>
  <role><roleTerm type="text">author</roleTerm> </role><identifier type="local">4430077</identifier></name>







<name type="corporate">
  <namePart/>
  <identifier type="local">2685187</identifier>
  <role>
    <roleTerm type="text">department</roleTerm>
  </role>
</name>








<abstract lang="eng">Among the cell populations existing within a tumor, cancer stem cells are responsible for metastasis formation and chemotherapeutic resistance. In the present review, we focus on the transcription factor NF-κB, which is present in every cell type including cancer stem cells. NF-κB is involved in pro-tumor inflammation by its target gene interleukin 1 (IL1) and can be activated by a feed-forward loop in an IL1-dependent manner. Here, we summarize current strategies targeting NF-κB by chemicals and biologicals within an integrated cancer therapy. Specifically, we start with a tyrosine kinase inhibitor targeting epidermal growth factor (EGF)-receptor-mediated phosphorylation. Furthermore, we summarize current strategies of multiple myeloma treatment involving lenalidomide, bortezomib, and dexamethasone as potential NF-κB inhibitors. Finally, we discuss programmed death-ligand 1 (PD-L1) as an NF-κB target gene and its role in checkpoint therapy. We conclude, that NF-κB inhibition by specific inhibitors of IκB kinase was of no clinical use but inhibition of upstream and downstream targets with drugs or biologicals might be a fruitful way to treat cancer stem cells.</abstract>

<relatedItem type="constituent">
  <location>
    <url displayLabel="biomedicines-10-00261-v2.pdf">https://pub.uni-bielefeld.de/download/2960810/2960811/biomedicines-10-00261-v2.pdf</url>
  </location>
  <physicalDescription><internetMediaType>application/pdf</internetMediaType></physicalDescription>
  <accessCondition type="restrictionOnAccess">no</accessCondition>
</relatedItem><accessCondition type="use and reproduction">https://creativecommons.org/licenses/by/4.0/</accessCondition>
<originInfo><publisher>MDPI AG</publisher><dateIssued encoding="w3cdtf">2022</dateIssued>
</originInfo>
<language><languageTerm authority="iso639-2b" type="code">eng</languageTerm>
</language>

<subject><topic>cancer stem cells</topic><topic>NF-κB</topic><topic>EGF</topic><topic>PD-L1</topic><topic>lenalidomide</topic><topic>bortezomib</topic><topic>dexamethason</topic>
</subject>


<relatedItem type="host"><titleInfo><title>Biomedicines</title></titleInfo>
  <identifier type="eIssn">2227-9059</identifier>
  <identifier type="MEDLINE">35203471</identifier><identifier type="urn">urn:nbn:de:0070-pub-29608107</identifier><identifier type="doi">10.3390/biomedicines10020261</identifier>
<part><detail type="volume"><number>10</number></detail><detail type="issue"><number>2</number></detail>
</part>
</relatedItem>


<extension>
<bibliographicCitation>
<bio1>Kaltschmidt B, Witte K, Greiner J, Weissinger F, Kaltschmidt C (2022) &lt;br /&gt;Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review.&lt;br /&gt;Biomedicines 10(2): 261.</bio1>
<angewandte-chemie>B.  Kaltschmidt, K.  Witte, J.  Greiner, F.  Weissinger, and C.  Kaltschmidt, “Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review”, &lt;em&gt;Biomedicines&lt;/em&gt;, &lt;strong&gt;2022&lt;/strong&gt;, &lt;em&gt;10&lt;/em&gt;, : 261.</angewandte-chemie>
<dgps>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Kaltschmidt, B., Witte, K., Greiner, J., Weissinger, F. &amp;amp; Kaltschmidt, C. (2022). Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. &lt;em&gt;Biomedicines&lt;/em&gt;, &lt;em&gt;10&lt;/em&gt;(2): 261. MDPI AG. doi:10.3390/biomedicines10020261.&lt;/div&gt;</dgps>
<chicago>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Kaltschmidt, Barbara, Witte, Kaya, Greiner, Johannes, Weissinger, Florian, and Kaltschmidt, Christian. 2022. “Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review”. &lt;em&gt;Biomedicines&lt;/em&gt; 10 (2): 261.&lt;/div&gt;</chicago>
<lncs> Kaltschmidt, B., Witte, K., Greiner, J., Weissinger, F., Kaltschmidt, C.: Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. Biomedicines. 10, : 261 (2022).</lncs>
<ama>Kaltschmidt B, Witte K, Greiner J, Weissinger F, Kaltschmidt C. Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. &lt;em&gt;Biomedicines&lt;/em&gt;. 2022;10(2): 261.</ama>
<default>Kaltschmidt B, Witte K, Greiner J, Weissinger F, Kaltschmidt C (2022) &lt;br /&gt;&lt;em&gt;Biomedicines&lt;/em&gt; 10(2): 261.</default>
<mla>Kaltschmidt, Barbara, Witte, Kaya, Greiner, Johannes, Weissinger, Florian, and Kaltschmidt, Christian. “Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review”. &lt;em&gt;Biomedicines&lt;/em&gt; 10.2 (2022): 261.</mla>
<frontiers>Kaltschmidt, B., Witte, K., Greiner, J., Weissinger, F., and Kaltschmidt, C. (2022). Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. &lt;em&gt;Biomedicines&lt;/em&gt; 10:261.</frontiers>
<apa_indent>&lt;div style="text-indent:-25px; padding-left:25px;padding-bottom:0px;"&gt;Kaltschmidt, B., Witte, K., Greiner, J., Weissinger, F., &amp;amp; Kaltschmidt, C. (2022). Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. &lt;em&gt;Biomedicines&lt;/em&gt;, &lt;em&gt;10&lt;/em&gt;(2), 261. &lt;a href="https://doi.org/10.3390/biomedicines10020261" target="_blank"&gt;https://doi.org/10.3390/biomedicines10020261&lt;/a&gt;&lt;/div&gt;</apa_indent>
<wels>Kaltschmidt, B.; Witte, K.; Greiner, J.; Weissinger, F.; Kaltschmidt, C. (2022): Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review &lt;em&gt;Biomedicines&lt;/em&gt;,10:(2):261</wels>
<apa>Kaltschmidt, B., Witte, K., Greiner, J., Weissinger, F., &amp;amp; Kaltschmidt, C. (2022). Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. &lt;em&gt;Biomedicines&lt;/em&gt;, &lt;em&gt;10&lt;/em&gt;(2), 261. &lt;a href="https://doi.org/10.3390/biomedicines10020261" target="_blank"&gt;https://doi.org/10.3390/biomedicines10020261&lt;/a&gt;</apa>
<ieee> B. Kaltschmidt, et al., “Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review”, &lt;em&gt;Biomedicines&lt;/em&gt;,  vol. 10, 2022, : 261.</ieee>
<harvard1>Kaltschmidt, B., et al., 2022. Targeting NF-κB Signaling in Cancer Stem Cells: A Narrative Review. &lt;em&gt;Biomedicines&lt;/em&gt;, 10(2): 261.</harvard1>
</bibliographicCitation>
</extension>
<recordInfo><recordIdentifier>2960810</recordIdentifier><recordCreationDate encoding="w3cdtf">2022-01-27T07:33:54Z</recordCreationDate><recordChangeDate encoding="w3cdtf">2022-04-01T15:30:24Z</recordChangeDate>
</recordInfo>
</mods>